(Click the links to download these presentations)
ADNI Symposium Presentation
Presentation to ICAD
July 27, 2008
Dr. Michael W. Weiner
ADNI Preliminary Results, July 2008: Comparative and Longitudinal Results
Presentation to ISAB at ICAD, Chicago
ADNI Biostatistics Core, UC Davis
Laurel Beckett, PhD
Danielle Harvey, PhD
Hao Zhang, MS
ICAD Chicago 2008 ADNI Abstracts
Oral Presentations
i. Weiner MW. Alzheimer’s Disease Neuroimaging Initiative (ADNI):
Progress Report. S1-01-01, Page T99. (PL-05-02) The evolution of
Alzheimer's disease clinical trial design
ii. Paul S. Aisen, University of California, San Diego, San Diego, CA, USA. Plenary PL-05. Plenary 5
iii. Apostolova LG, Morra JH, Green AH, Hwang K,
Avedissian C, Parikshak N, Cummings JL, Toga AW, Jack CR, Weiner MW,
Thompson PM. Automated Longitudinal 3-D Mapping of Hippocampal ADAS-cog
Delayed Recall Effects in 293 Normal Elderly, Mild Cognitive Impairment
and Alzheimer’s Disease Subjects. O1-02-05, Page T110.
iv. Reiman EM, Chen K, Ayutyanont N, Lee W, Bandy D, Reschke C,
Alexander GE, Weiner MW, Koeppe RA, Foster NL, Jagust WJ. Twelve-Month
Cerebral Metabolic Declines in Probable Alzheimer’s Disease and
Amnestic Mild Cognitive Impairment: Preliminary Findings From the
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
v. Schuff N, Woerner N, Boreta L, Kornfield T, Jack Jr. CR, Weiner
MW. Rate of Hippocampal Atrophy in the Alzheimer’s Disease Neuroimaging
Initiative (ADNI): Effects of ApoE4 and Value of Additional MRI Scans.
O3-03-06, Page T164.
vi. Donohue M, Aisen P, Gamst A, Weiner M. Using the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) Data to Improve Power For
Clinical Trials